Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colonic Neoplasms 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Lymphatic Metastasis 2 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stage IV or Unresectable Gastric Cancer 1 Pilonidal Sinus 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Malignant Neoplasm of Transverse Colon 1 Locally Advanced Gastric Cancer 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Colorectal Liver Metastasis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

aldesleukin 42 Sunitinib 39 Cyclophosphamide 30 Nivolumab 27 Everolimus 27 pembrolizumab 26 Interferon-alpha 25 Bevacizumab 22 Sorafenib 21 Interleukin-2 20 fludarabine phosphate 19 Filgrastim 18 Ipilimumab 17 Radiotherapy 16 Axitinib 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 cabozantinib 14 fludarabine 11 Radiosurgery 11 Doxorubicin 11 Carboplatin 11 temsirolimus 10 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8 belzutifan 8 atezolizumab 8 Fluorouracil 8 pazopanib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × Conversion to Open Surgery × Clear all

NCT03849820 2025-06-17

OpeRa

Intuitive Surgical

Phase NA Terminated

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡